Related Experiment Video
Updated: Sep 20, 2025
08:17
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
14.7K
Inflammation in Myeloid Malignancies: From Bench to Bedside
Eli M Soyfer1, Angela G Fleischman2,3
1School of Medicine, University of California, Irvine, CA, USA.
Journal of Immunotherapy and Precision Oncology
|June 6, 2022
Summary
Inflammation is a key feature in myeloid malignancies, from early stages to acute myeloid leukemia (AML). Understanding basic science findings on inflammation could improve patient diagnosis, prognosis, and treatment strategies.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Myeloid malignancies originate from somatically mutated hematopoietic clones.
- These conditions present with diverse clinical outcomes like pancytopenia, lineage overproduction, or immature cell proliferation.
- Inflammation is increasingly recognized as a common characteristic across the spectrum of clonal myeloid disorders.
Purpose of the Study:
- To review fundamental basic science findings on the role of inflammation in myeloid malignancies.
- To explore the potential clinical implications of these findings for patient care.
Main Methods:
- Literature review of basic science research on inflammation in myeloid malignancies.
- Synthesis of findings to connect laboratory research with clinical applications.
Main Results:
- Basic science research highlights inflammation as a central mechanism in myeloid malignancies.
- Inflammatory pathways are implicated from clonal hematopoiesis to acute myeloid leukemia (AML).
Conclusions:
- Basic science insights into inflammation offer potential for improved diagnostic and prognostic tools.
- Translating these findings may lead to novel therapeutic strategies for myeloid malignancies.
